SiRNA targeting hepatoma-derived growth factor (HDGF) inhibits growth of non-small cell lung cancer in xenograft models.

被引：0
|
作者：
Zhang, Jun
Mao, Li
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] China Med Univ, Dept Thorac Surg, Clin Coll 1, Shenyang, Liaoning, Peoples R China
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5135
引用
收藏
页数：2
相关论文
共 50 条
  • [11] The relationship between hepatoma-derived growth factor and prognosis in non-small cell lung cancer A systematic review and meta-analysis
    Koh, Hyun Min
    Hyun, Chang Lim
    Jang, Bo Gun
    Lee, Hyun Ju
    MEDICINE, 2020, 99 (51) : E23837
  • [12] Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells
    Kishima, Y
    Yoshida, K
    Enomoto, H
    Yamamoto, M
    Kuroda, T
    Okuda, Y
    Uyama, H
    Nakamura, H
    HEPATO-GASTROENTEROLOGY, 2002, 49 (48) : 1639 - 1644
  • [13] Antibodies targeting hepatoma-derived growth factor as a novel strategy in treating lung cancer
    Ren, Hening
    Chu, Zuoming
    Mao, Li
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) : 1106 - 1112
  • [14] Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells
    Sun, Ai-Min
    Li, Chuan-Gang
    Zhang, Yu-Qin
    Lin, Shui-Miao
    Niu, Hua-Rui
    Shi, Yu-Sheng
    CYTOKINE, 2015, 72 (01) : 31 - 35
  • [15] HDGF (hepatoma-derived growth factor)-silencing inhibits the proliferation of hepatoma cells through a sorafenib-independent pathway
    Enomoto, Hirayuki
    Nakamura, Hideji
    Imanishi, Hiroyasu
    Ishii, Noriko
    Yuri, Yukihisa
    Aoki, Tomoko
    Yoh, Kazunori
    Ishii, Akio
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Iijima, Hiroko
    Nishiguchi, Shuhei
    HEPATOLOGY, 2013, 58 : 1068A - 1068A
  • [16] miR-4323 targets hepatoma-derived growth factor (HDGF) to suppress colorectal cancer cell proliferation
    Xia, Cuifeng
    Li, Qiang
    Cheng, Xianshuo
    Wu, Tao
    Gao, Pin
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 225
  • [17] HEPATOMA-DERIVED GROWTH FACTOR (HDGF) IS AN ONCOGENE ON CHROMOSOME 1Q IN LIVER CANCER
    Hu, Tsung-Hui
    HEPATOLOGY, 2024, 80
  • [18] Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer
    Chen, Xiaoyan
    Yun, Jun
    Fei, Fei
    Yi, Jun
    Tian, Ruifeng
    Li, Sanzhong
    Gan, Xiaoqiang
    PATHOLOGY RESEARCH AND PRACTICE, 2012, 208 (08) : 437 - 443
  • [19] Targeting LUNX Inhibits Non-Small Cell Lung Cancer Growth and Metastasis
    Zheng, Xiaohu
    Cheng, Min
    Fu, Binqing
    Fan, Xiaolei
    Wang, Qing
    Yu, Xiaoqing
    Sun, Rui
    Tian, Zhigang
    Wei, Haiming
    CANCER RESEARCH, 2015, 75 (06) : 1080 - 1090
  • [20] miR-134 inhibits non-small cell lung cancer growth by targeting the epidermal growth factor receptor
    Qin, Qin
    Wei, Furong
    Zhang, Jianbo
    Wang, Xingwu
    Li, Baosheng
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (10) : 1974 - 1983
12345